Core Viewpoint - The company is a leading domestic precision stamping materials enterprise, contributing to the localization of key materials and is the only listed company in the precision stamping materials industry in China [1] Group 1: Company Overview - The company focuses on precision stamping materials, primarily special steel, with downstream applications in automotive parts and industrial sectors, and is expanding into emerging fields like humanoid robots [1] - Major shareholders are core management personnel, ensuring stable control, and the full subscription of the private placement by the actual controller reflects confidence in development [1] Group 2: Financial Performance - From 2020 to 2024, the company's revenue is expected to grow from 712 million to 1.485 billion yuan, while net profit attributable to the parent company is projected to increase from 68 million to 207 million yuan, indicating continuous improvement in profitability [1] - The expense ratio remains relatively stable, and raw material prices are on a downward trend with controllable risks [1] Group 3: Industry Insights - Precision stamping is a high-precision processing method widely used in automotive, electronics, and home appliances, with the global stamping parts market steadily growing and China's market share increasing [2] - The precision stamping steel market is expanding as China's manufacturing industry undergoes transformation and upgrading, with automotive being the primary downstream market [2] Group 4: Production Capacity and Technology - The company ranks among the top tier in the industry in terms of production capacity, with an expected capacity of approximately 180,000 tons in 2024, and the first batch of 40,000 tons of high-end capacity is set to be released in Q2 2025 [3] - The company possesses multiple core technologies, with some product key indicators comparable to international leading special steel material companies [3] Group 5: Market Applications - The company is deepening its presence in the automotive parts sector while exploring diversified end applications, including bearings and humanoid robots [4] - The automotive market is expected to benefit from cost reduction and domestic substitution, while the bearing steel production is anticipated to shift towards rod and wire materials [4] Group 6: Investment Projections - Revenue forecasts for 2025-2027 are set at 1.782 billion, 2.188 billion, and 2.674 billion yuan, with net profits projected at 241 million, 291 million, and 357 million yuan respectively, indicating a strong growth trajectory [5] - The company is the only listed precision stamping materials company in China, making it a unique investment opportunity in the A-share market [5]

Core Viewpoint - The article discusses the supply chain issues and investment opportunities in the semiconductor chemical mechanical polishing (CMP) materials market, particularly focusing on the impact of Taiwan's export controls on the supply of DSTl slurry and the growth potential of CMP materials in the semiconductor industry. Group 1: CMP Slurry Supply Issues - DSTl slurry supply has been suspended due to Taiwan's export control restrictions, with only five months of inventory remaining (267 barrels) [2] - DSTl slurry is critical for the CMP process in semiconductor manufacturing, enhancing wafer flatness and surface quality [2] Group 2: Investment Logic in CMP Materials - The demand for CMP materials is expected to grow rapidly due to advancements in process nodes, increased wiring density, and the transition from 2D NAND to 3D NAND technology [4] - CMP materials account for 7% of the semiconductor manufacturing material costs, with CMP slurry and pads making up 49% and 33% of CMP material costs, respectively [4] - The global CMP materials market is projected to grow from $3.3 billion in 2023 to over $4.2 billion by 2027 [4] Group 3: CMP Pad Market Overview - The global CMP pad market grew from $650 million in 2016 to $1.13 billion in 2021, with a CAGR of 11.69% [5] - In China, the CMP pad market increased from 810 million yuan in 2016 to 1.31 billion yuan in 2021, with a CAGR of 10.09% [5] - Dow DuPont dominates the global CMP pad market with a 79% share, while domestic company Dinglong has become a key player in China [6] Group 4: CMP Slurry Market Overview - The global CMP slurry market expanded from $1.1 billion in 2016 to $1.43 billion in 2021, with a CAGR of 5.39% [7] - The Chinese CMP slurry market grew significantly, from 1.23 billion yuan in 2016 to 2.2 billion yuan in 2021, with a CAGR of 12.28% [7] - Major global players in the CMP slurry market include Cabot, Versum Materials, and Dow, with China being the largest demand region [7] Group 5: Domestic Companies in CMP Materials - Dinglong has established itself as the only domestic supplier mastering the entire CMP pad production process, achieving significant breakthroughs in the field [6][12] - Anji Technology, a leading domestic CMP slurry company, reported revenues of 1.075 billion yuan in 2023, capturing a significant market share [22][23] - Shanghai Xinyang and Jiangfeng Electronics are also notable players in the CMP materials sector, focusing on various CMP products [36][37] Group 6: Future Trends and Opportunities - The future of CMP materials is expected to trend towards specialization and customization, providing opportunities for new entrants in the market [8] - Companies focusing on new technologies for polishing liquids, such as those related to SiC, and those mastering upstream particle development are recommended for investment [8]

Group 1 - The core viewpoint of the article highlights the ongoing competition between China's resource advantages in tungsten and the West's efforts to protect domestic industries, leading to a restructuring of the global supply chain [2][3][6] - The global tungsten industry is characterized by a simultaneous struggle for resource control and technological upgrades, reflecting the broader industrial competition among developed nations [3][7][9] Group 2 - China's tungsten industry policy aims for transformation and upgrading, with a focus on controlling exports and enhancing technological capabilities [10][12][14] - The U.S. seeks to reduce dependency on Chinese tungsten through tariffs and by rebuilding critical industry nodes, facing challenges in cost, technology, and coordination with allies [17][21][23] Group 3 - The overall export volume of tungsten from China is declining, with a shift towards high-value-added products [33][34] - The concentration of tungsten resource flows is high, with differentiated export demands across markets [48][49] Group 4 - The article emphasizes the strategic significance of hard alloy tools in the tungsten industry, with a focus on emerging markets like Russia and ASEAN countries, as well as the impact of geopolitical factors on regional procurement [61][62][71] - The demand for cutting tools, particularly hard alloy tools, is expected to grow due to their essential role in high-end manufacturing sectors [61][62]

【摘要】近日，燧原科技发布第三期上市辅导工作进展情况报告，公司或冲击A股科创板上市。 报告显示，公司IPO的募集资金已确定初步投向，整体规模及募投项目可行性、收益情况还在持续论证 当中。 据知情人士透露，燧原科技已在近期退出某参股企业股东名列，或为上市做准备。 2018年成立仅一个月，燧原就获得亦合资本、真格基金的种子轮投资；五个月后，腾讯以3.4亿元领投 Pre-A轮，开启连续六轮注资的"热启动战略"。 截止目前，燧原科技已完成了十轮融资，累计融资金额近70亿元，公司以160亿元估值登上胡润"2024全 球独角兽榜"。 数据显示，腾讯是燧原的第一大股东，持股比例约20.5%，半导体产业基金武岳峰资本、国家半导体集 成电路基金都位列燧原的股东名单。 在上市的重要关头，剥离非核心资产、规避同业竞争、聚焦主营业务，或成为公司冲刺A股IPO的理性 选择。 近年来，AI芯片国产替代成为业界的共同呼声，除燧原以外，沐曦集成、壁仞科技、摩尔线程也纷纷 开启上市计划。 巨额研发投入下，AI芯片企业的盈利压力仍较为明显。 此外，部分业内人士也表示，AI技术应用带动芯片需求增长，但随着企业增多，可能出现结构性产能 过剩或局部市 ...

Market Overview - On July 1, 2025, the A-share market exhibited a mixed performance with significant differentiation among the three major indices. The Shanghai Composite Index closed at 3457.75 points, up 13.32 points or 0.39%, with a trading volume of 553.6 billion yuan, indicating strong support from large-cap blue-chip stocks [2][3] - The Shenzhen Component Index closed at 10476.29 points, up 11.17 points or 0.11%, with a trading volume of 912.5 billion yuan, reflecting the overall performance of various enterprises in the Shenzhen market [2][3] - The ChiNext Index fell by 5.09 points or 0.24%, closing at 2147.92 points, with a trading volume of 444.4 billion yuan, showing relative weakness influenced by fluctuations in technology growth stocks [2][3] Sector Performance - The pharmaceutical and biotechnology sector emerged as the biggest highlight of the day, surging after the National Healthcare Security Administration introduced measures to support the high-quality development of innovative drugs. Notable stocks included Yangpu Medical, which hit a 20% limit up within 8 minutes, and several others like Seli Medical and Guizhou Bai Ling also reached their limit up [4][5] - The semiconductor sector also showed strong performance, particularly in the photolithography machine segment, with the sector index rising nearly 3% and reaching a historical high. Stocks like Blue Ying Equipment and Changqing Technology saw significant gains [6][7] Market Dynamics - Despite the strong performance in certain sectors, others such as diversified finance, software development, and communication services faced declines. The previously popular digital currency and solid-state battery sectors also experienced corrections as market enthusiasm waned, leading to profit-taking and valuation adjustments [8] - The total trading volume in the Shanghai and Shenzhen markets was 1.49657 trillion yuan, a decrease of 20.5 billion yuan from the previous trading day, indicating a cautious stance from market participants as they navigate the beginning of the second half of the year [8] Capital Flow - There was a noticeable shift in capital flow, with main funds moving away from previously high-performing sectors to those with high earnings certainty and strong policy support, such as pharmaceuticals and technology [10] - The market is expected to continue presenting structural opportunities amid fluctuations, supported by macro-level policy benefits and potential liquidity measures from the central bank [10] Investment Opportunities - The technology sector remains a key focus, particularly in AI and semiconductor industries, which are expected to benefit from increasing penetration and domestic substitution trends. Companies like SMIC and Cambrian are positioned for growth [12] - The consumer sector, especially in electric vehicles and smart home appliances, is also highlighted for potential growth, with companies like BYD and Midea Group expected to capitalize on market demand [12]

Group 1: Semiconductor Industry - The semiconductor sector is experiencing significant growth, with companies like Moer Thread and Muxi Integrated Circuit having their IPO applications accepted, indicating a strong focus on domestic substitution [3] - The National Big Fund has invested 114 billion in the semiconductor industry, and predictions suggest that by 2030, mainland China will become the largest wafer foundry center globally, highlighting a substantial industry upgrade [3] - Companies with high technical barriers and clear orders, such as Xuanji Information, which has produced AI inference chips supporting 130 billion parameters, are positioned well for long-term growth [3] Group 2: Nuclear Power Sector - Google has made a historic purchase of 200 megawatts of fusion power, marking a significant step towards commercializing fusion energy [4] - State-owned enterprises like China National Petroleum and China National Nuclear Corporation are heavily investing in this area, ensuring a high level of order certainty for components under the new infrastructure logic [4] - Companies like Great Wall Electric and Sichuan Electronics, which are core suppliers of nuclear power equipment, have secured substantial orders, with one Shanghai nuclear enterprise recently obtaining over 50 billion in orders [4] Group 3: Military Industry - The military sector is seeing increased activity, with companies like Great Wall Military experiencing significant stock price increases, driven by government support for strategic emerging industries [4] - The demand for marine engineering and underwater intelligent equipment is rising, as evidenced by the surge in orders for companies like China Shipbuilding [4] - A dual strategy of "event-driven + performance verification" is recommended for investing in military stocks, particularly those with expected asset injections [4] Group 4: Innovative Pharmaceuticals - The innovative pharmaceutical sector is revitalizing, with companies like Anglikang and Shutaishen reaching historical highs following new policies from the Medical Insurance Bureau that support R&D and payment pathways [4] - Companies with significant clinical value, such as Frontline Bio's anti-HIV drug and Rongchang Bio's ADC drug, are highlighted as worthy of long-term tracking [4] - Caution is advised against companies that are merely concept-driven, emphasizing the importance of those with substantial pipelines entering Phase III clinical trials [4] Group 5: Market Trends and Strategies - Key investment themes include domestic substitution in semiconductors, commercialization breakthroughs in nuclear power, policy benefits in the military sector, and payment reforms in innovative pharmaceuticals [5] - The strategy emphasizes low-position entry over chasing high prices, the importance of technical barriers in determining holding periods, and the need for policy catalysts to align with performance verification [5]

Core Insights - The article highlights the rapid development of the domestic analog chip industry in China, driven by the transition from a "demographic dividend" to an "engineer dividend" in the economy [1] - Texas Instruments (TI) has established itself as a leader in the analog chip market, with a significant market share following its acquisition of National Semiconductor [1] - The analog chip sector is characterized by high technical and talent barriers, making it a challenging field for new entrants [1][6] Group 1: Analog Chip Overview - Analog integrated circuits (ICs) are essential for processing continuous signals and are widely used across various industries, including consumer electronics, automotive, and 5G [2] - The analog chip market can be divided into application-specific standard products (ASSPs) and general-purpose chips, with ASSPs accounting for approximately 50% of the market [3] - The market for power management chips is larger than that for general signal chain chips, with power management chips crucial for voltage regulation in electronic devices [4] Group 2: Challenges in the Analog Chip Industry - The analog chip market is fragmented with a vast array of product types, making it difficult for new entrants to meet diverse customer needs [6] - The lengthy R&D cycle and significant talent barriers pose challenges for companies looking to innovate in the analog chip space [7] - Companies must develop core competencies in technology breakthroughs, product development, and international market strategies to succeed [7] Group 3: Domestic Advancements in Analog Chips - Chinese companies have made significant strides in the analog chip sector, particularly in the ADC (Analog-to-Digital Converter) market, which has been dominated by TI and ADI [8][9] - Domestic firms like Xinwei Microelectronics and HiSilicon have launched competitive ADC products, narrowing the gap with international leaders [8][9] - The establishment of collaborative platforms and laboratories is further promoting the development of domestic analog chip technology [9] Group 4: Mergers and Acquisitions in the Industry - Domestic analog chip companies are pursuing mergers and acquisitions to enhance product lines and market presence [10][11] - Recent acquisitions, such as those by Sireen and Naxin Micro, indicate a trend towards platform-based strategies in the industry [11][12] - The consolidation of smaller firms through M&A is seen as a viable path for growth and competitiveness in the analog chip market [13]

Core Insights - The Chinese medical device industry is projected to reach a market size of 1.2 trillion yuan by 2024, with logistics warehouse space totaling 23.58 million square meters and over 40,000 vehicles for medical logistics transportation [1] - The government is enhancing policy support for the medical device industry, focusing on expediting clinical trials and approvals for innovative medical devices [2][3] - Companies are actively expanding their market presence and capabilities in response to policy incentives and growing market demand [4][5] Industry Growth and Policy Support - The State Council has issued opinions to reform drug and medical device regulation, aiming to shorten clinical trial and registration timelines, particularly for high-end devices like medical robots and brain-computer interfaces [2] - Local governments, such as Zhejiang and Shanxi, are implementing measures to support innovation in medical devices, including expedited approval processes and enhanced healthcare coverage for innovative products [2][3] Company Strategies and Market Expansion - Companies like Di'an Diagnostics are leveraging AI and data to enhance their product offerings, with their AI pathology model achieving clinical-grade standards [4] - Kangji Medical's surgical robot has been approved for market release, marking a significant step in domestic production capabilities and reducing reliance on imports [4] - Yingte Group is investing in a modern pharmaceutical supply chain park to improve logistics capabilities, indicating a trend towards digital and intelligent solutions in the medical supply chain [5] - The medical device sector is becoming a key area for diversified growth among listed companies, driven by aging populations and supportive policies [5]

证券分析师：王艺熹 021-60893204 wangyixi@guosen.com.cn S0980522100006 证券研究报告 | 2025年7月1日 转债市场研判及"十强转债"组合 2025年7月 投资策略 · 固定收益 国信宏观固收 证券分析师：赵婧 0755-22940745 zhaojing@guosen.com.cn S0980513080004 证券分析师：董德志 021-60933158 dongdz@guosen.com.cn S0980513100001 02 2025年7月转债配置策略 联系人：吴越 021-60375496 wuyue8@guosen.com.cn 请务必阅读正文之后的免责声明及其项下所有内容 目录 01 2025年6月转债市场回顾 03 2025年7月"十强转债"组合 请务必阅读正文之后的免责声明及其项下所有内容 • 股市方面，6月权益市场震荡上涨，尤其下旬在中东局势缓和、以及稳定币、小米汽车、军 贸等多项热点题材的催化之下，沪指再次站上3400点，截至6月27日沪指收于3424.2，全月 涨1.85%。申万一级行业多数收涨，受产业订单预期向好拉动的通信（+12 ...

Group 1 - The A-share technology sector experienced a strong opening on July 1, with the semiconductor industry chain leading the gains, particularly in areas such as photolithography machines and advanced packaging [1][7] - Several stocks, including Kai Mei Te Qi and Hai Li Shares, reached their daily limit, while Blue Ying Equipment surged over 16% and Jiu Ri New Materials increased by over 5% [2][3] - The semiconductor and chip concepts have seen a wave of limit-up stocks, with significant gains in the photolithography machine sector, which has risen over 11% in the last seven trading days [4][5] Group 2 - Recent market rumors suggest a major breakthrough in domestic EUV photolithography machines, with reports indicating that the National Integrated Circuit Industry Investment Fund is adjusting its focus to address key shortcomings in photolithography machines and EDA software [7] - The Chinese government emphasizes the importance of technological self-reliance, with recent meetings highlighting the need to accelerate breakthroughs in core technologies and enhance national security [8][9] - The semiconductor wafer manufacturing equipment market in mainland China is projected to reach over 230 billion yuan in 2024, with a year-on-year growth of 19.4% [9] Group 3 - SEMI forecasts that by 2025, the self-sufficiency rate of domestic chip equipment will reach 50%, with full coverage of 14nm processes, reducing dependence on equipment from the US, Japan, and Europe [10] - The outlook for domestic substitution is promising, with strong momentum in the artificial intelligence sector, and J.P. Morgan predicts a potential 15%-20% increase in Asian tech stocks this year [11] - Minsheng Securities notes that the high-end photolithography machine market is currently dominated by ASML, Nikon, and Canon, indicating a significant market opportunity for domestic breakthroughs in certain categories [13] Group 4 - The domestic semiconductor industry is experiencing a wave of mergers and acquisitions, with companies across various sectors, including materials, equipment, and chip design, actively pursuing consolidation strategies [14] - Mergers are seen as a core strategy for companies to quickly acquire key technologies and maintain market competitiveness, especially in the context of accelerating domestic substitution [15]